Adma Biologics (ADMA) EBIT (QoQ) (2011 - 2025)
Adma Biologics (ADMA) EBIT (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Adma Biologics | 2.13 Bn | 2.00 Bn | 86.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 23.01% |
| Sep 30, 2025 | 19.19% |
| Jun 30, 2025 | 22.70% |
| Mar 31, 2025 | -8.98% |
| Dec 31, 2024 | -3.32% |
| Sep 30, 2024 | 1.11% |
| Jun 30, 2024 | 79.65% |
| Mar 31, 2024 | 53.31% |
| Dec 31, 2023 | 63.88% |
| Sep 30, 2023 | 1,936.15% |
| Jun 30, 2023 | 41.82% |
| Mar 31, 2023 | 86.58% |
| Dec 31, 2022 | 34.97% |
| Sep 30, 2022 | -1.55% |
| Jun 30, 2022 | 38.07% |
| Mar 31, 2022 | -12.31% |
| Dec 31, 2021 | 8.63% |
| Sep 30, 2021 | 7.34% |
| Jun 30, 2021 | -2.75% |
| Mar 31, 2021 | 11.94% |